Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study — Ply Chichareon (2019) | RDL Network
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study
International Journal of Cardiology 286: 43-50
Article 2019 English
Authors
PC
Ply Chichareon
RM
Rodrigo Modolo
DK
David van Klaveren
Abstract
1 min read
Background
ACEF score has been shown to have predictive ability in the patients undergoing percutaneous coronary intervention (PCI). The ACEF II score has recently been developed to predict short-term mortality after cardiac surgery. We compared the predictive ability of the ACEF and ACEF II scores to predict mortality after PCI in the all-comers population.
Methods
The ACEF and ACEF II scores were calculated in 15,968 patients enrolled in the GLOBAL LEADERS study. Discrimination and calibration were assessed for outcomes after PCI. Recalibration of the regression model by updating the intercept and slope were performed to adjust the original ACEF model to the PCI setting. In a stratified approach, patients were divided into quintiles according to the score. Outcomes were compared between quintiles.
Results
The ACEF and ACEF II score were available in 14,941 and 14,355 patients respectively. Discrimination for 30-day all-cause mortality was acceptable for both scores (C-statistic ACEF 0.75 and ACEF II 0.77). For 2-year all-cause mortality, the discrimination of ACEF score was acceptable (C-statistic 0.72) while the discrimination of ACEF II score was moderate (C-statistic 0.69). Both scores identified patients at high risk of mortality but overestimated all-cause mortality at 30 days in all quintiles. After recalibration, agreement between predicted and observed 30-day all-cause mortality in both scores are close to the identity line.
Conclusions
The ACEF II model did not improve the predictive ability of the ACEF score. Recalibrated ACEF model can be used to estimated all-cause mortality rate at 30 days after PCI.
Ply Chichareon, Yoshinobu Onuma, David van Klaveren, Rodrigo Modolo, Norihiro Kogame, Kuniaki Takahashi, Chun Chin Chang, Mariusz Tomaniak, Taku Asano, Yuki Katagiri, Robert‐Jan van Geuns, Leonardo Bolognese, Carlo Tumscitz, Mathias Vrolix, Ivo Petrov, Scot Garg, Christoph Naber, Manel Sabaté, Javaid Iqbal, Joanna J. Wykrzykowska, Jan J. Piek, Ernest Spitzer, Peter Jüni, Christian W. Hamm, Philippe Gabríel Steg, Marco Valgimigli, Pascal Vranckx, Stephan Windecker, Patrick W. Serruys
Masafumi Ono, Hideyuki Kawashima, Hironori Hara, Amr Gamal, Rutao Wang, Chao Gao, Neil O’Leary, Osama Soliman, Jan J. Piek, Robert‐Jan van Geuns, Peter Jüni, Christian W. Hamm, Marco Valgimigli, Pascal Vranckx, Stephan Windecker, Philippe Gabríel Steg, Keith A.A. Fox, Yoshinobu Onuma, Patrick W. Serruys
Hidenori Komiyama, Ply Chichareon, Christian W. Hamm, Peter Jüni, Marco Valgimigli, P Vranckx, Stephan Windecker, Yoshinobu Onuma, G Stegg, Patrick W. Serruys
Joanna J. Wykrzykowska, Scot Garg, Yoshinobu Onuma, Ton de Vries, Dick Goedhart, Marie-Angèle Morel, Gerrit‐Anne van Es, Paweł Buszman, Axel Linke, Thomas Ischinger, Volker Klauß, Roberto Corti, Franz R. Eberli, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Robert‐Jan van Geuns, Peter Jüni, Stephan Windecker, Patrick W. Serruys
Rodrigo Modolo, Ply Chichareon, David van Klaveren, Ovidiu Dressler, Yiran Zhang, Joseph F. Sabik, Yoshinobu Onuma, A. Pieter Kappetein, Gregg W. Stone, Patrick W. Serruys
Discussion(0)
No comments yet. Be the first to comment.